Drugs / UQSC2
last change Dec 2023 re-read 2 minutes ago

UQSC2

Vaccine

Developed for
COVID-19
Investigated by
Coalition for Epidemic Preparedness Innovations · The University of Queensland

Trials 1 · a red edge is where a trial was stopped

202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT05775887 May → Dec 2023 COVID-19 The University of Queensland Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as UQSC2 ClinicalTrials.gov intervention name — accepted as the source's own label NCT05775887
Modality Vaccine “UQSC2 vaccineNCT05775887